glp 1 agonist dosing Injections of an ultra-long-acting investigational GLP-1 led to significant weight loss in people with overweight or obesity, with reductions continuing after a switch to once-monthly dosing, according to the ongoing VESPER GLP-1 receptor agonists in the

That turns a molecule designed for pulsatile behavior (in and out over a few hours) into something circulating at potentially 1,000 times normal elevation for nearly a week

Clinicians are uniquely positioned to identify patient-specific needs and integrate GLP-1R agonists into personalized treatment plans, especially for those with T2DM, obesity, and related metabolic conditions

Real-world experience from clinical programs and observational cohorts reinforce trial data and demonstrate more heterogeneity

Effectiveness of a digital therapeutic as adjunct to treatment with medication in pediatric ADHD

9 The Therapeutic Landscape of FcRn Antagonists Increasing IgG catabolism by specific FcRn targeting has proven to be a safe and efficacious strategy to lower the levels of autoreactive IgG in several autoimmune diseases

VL: Conceptualization, Writingoriginal draft, Writingreview and editing